AA
TNDM icon

Ancora Advisors’s Tandem Diabetes Care TNDM Stock Holding History

Ancora Advisors’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,230
Closed -$23.6K – 2357
2026
Q1 		$23.6K Buy
1,230
+870
+242% +$18.9K ﹤0.01% 1471
2025
Q4 		$7.91K Buy
+360
New +$6.5K ﹤0.01% 1847
2023
Q1 		– Sell
-94
Closed -$4K – 2054
2022
Q4 		$4K Hold
94
– – ﹤0.01% 1515
2022
Q3 		$4K Hold
94
– – ﹤0.01% 1697
2022
Q2 		$6K Hold
94
– – ﹤0.01% 1727
2022
Q1 		$11K Buy
94
+80
+571% +$9.34K ﹤0.01% 1709
2021
Q4 		$2K Buy
+14
New +$1.89K ﹤0.01% 2208

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Ancora Advisors's TNDM Position: Q2 2026 in Review

Ancora Advisors sold out of Tandem Diabetes Care (TNDM) in Q2 2026, closing a stake of 1,230 shares — an estimated $23.6K sold.

Ancora Advisors first reported a position in TNDM in Q4 2021 and held it in 7 quarters. The position peaked at $23.6K in Q1 2026. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Ancora Advisors reported no remaining Tandem Diabetes Care position as of Q2 2026 after selling out during the quarter.
  • Ancora Advisors sold 1,230 Tandem Diabetes Care shares in Q2 2026, an estimated $23.6K.
  • Ancora Advisors first reported a position in Tandem Diabetes Care in Q4 2021 and held it in 7 quarters.
  • Ancora Advisors's Tandem Diabetes Care position peaked at $23.6K in Q1 2026.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Ancora Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.